Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report

Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report

Nivolumab, a fully human IgG4 immune checkpoint inhibitor (ICI) antibody, has been approved for a variety of cancers. Several endocrine-associated immune-related adverse events have been reported, but the incidence rate is relatively low. This is a case of a patient with gastric cancer who underwent...

Full description

Bibliographic Details
Main Authors: Shoko Marshall, Aki Kizuki, Tadashi Kitaoji, Hiroshi Imada, Hayato Kato, Mana Hosoda, Motonao Ishikawa, Hiroshi Sakura
Format: Article
Language:English
Published: Karger Publishers 2020-09-01
Series:Case Reports in Oncology
Subjects:
nivolumab
type 1 diabetes
acth deficiency
hypothyroidism
Online Access:https://www.karger.com/Article/FullText/510044

Similar Items

Similar Items